Shanghai HeartCare Medical Technology Corporation Limited (06609) disclosed a repurchase of 3,000 H shares on October 20, 2025, at HKD 55.35 per share, totaling HKD 166,050. These shares transitioned into treasury shares, raising the company’s treasury holdings of H shares from 513,750 to 516,750.

As of October 20, 2025, the number of issued H shares (excluding treasury shares) stands at 31,049,054, with the unlisted shares remaining at 7,268,604. The total issued H shares and unlisted shares at the time of the special resolution was 38,834,408 shares, comprising 31,565,804 H shares and 7,268,604 unlisted shares.